Full Version of The International Journal of Targeted Therapies in Cancer from April 2013
April 2013
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
New Drug Application Filed for Savolitinib/Osimertinib in MET+ NSCLC
2
Proton Therapy Does Not Improve Survival in Advanced HCC Trial
3
FDA Oncology Recap: Approvals, Designations, and Decisions in September 2026
4
CD47-Targeted Evorpacept Shows Durable Responses in HER2+ Gastric Cancer
5